11 research outputs found
The biology of the northern brown bandicoot, Isoodon macrourus (Marsupialia: Peramelidae) at Mitchell Plateau, Western Australia
Breeding, population dynamics and seasonal changes in physical and physiological parameters were examined in Isoodon macrourus at the Mitchell Plateau between September 1981 and November 1982. Females gave birth to litters of 2.5 ± 1.0 (16) young between September and April. They produced up to three litters in a breeding season with an average interval between successive litters of 89.5 (51-108) days. Adult testosterone levels and scrota1 size began to increase in July and peaked in September 1982. The overall ratio of adult males to adult females was 1:0.54; it was 1:0.80 for pouch young. Females were more frequently trapped on sequential trips than were males. Density on the grids increased towards the end of the dry season (July and September 1982)-mostly as a result of increased numbers of females. Adult males and females moving onto the grids during the dry season tended to select different habitats. Adult males moved significantly more in the wet season (September 1981, January and April) than they did in the dry season (July and September 1982); they also moved significantly more than adult females in the wet season. Seasonal variations were recorded for most physical and physiological parameters. During the wet period from September 1981 to January 1982, body weight, haemoglobin, haematocrit and total plasma albumin declined, while total white blood cells and proportion of lymphocytes to granular leucocytes rose. This indicated that this period was one of change in condition for this species. Compared to adult females, adult males were larger and heavier, had higher values of haematocrit and lymphocytes, and lower values of granular leucocytes, free steroids, CBGBd and albumin bound corticosteroid. There was considerable between-year variability in condition of individuals and both sexes differed significantly in September 1981 and 1982 in their weight, haematocrit, total white blood cells, granular leucocytes, MCBC and testosterone. Individuals at disparate localities at the Mitchell Plateau showed similar seasonal physiological and physical responses, except for one grid where they were heavier.C. Kemper, D. J. Kitchener, W. F. Humphreys, R. A. How, L. H. Schmitt and A. Bradle
Fabrication of a Modular Neutron Array: A Collaborative Approach to Undergraduate Research
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Rationale: Targeted cystic fibrosis (CF) therapy with lumacaftor/ivacaftor partly restores chloride channel function and improves epithelial fluid transport in the airways. Consequently, changes may occur in the microbiome, which is adapted to CF lungs. Objectives: To investigate the effects of lumacaftor/ivacaftor on respiratory microbial composition and microbial metabolic activity by repeatedly sampling the lower respiratory tract. Methods: This was a single-centre longitudinal observational cohort study in adult CF patients with a homozygous Phe508del mutation. Lung function measurements and microbial cultures of sputum were performed as part of routine care. An oral and nasal wash, and a breath sample, were collected before and every 3 months after starting therapy, for up to 12 months. Results: Twenty patients were included in this study. Amplicon 16S RNA and metagenomics sequencing revealed that Pseudomonas aeruginosa was most abundant in sputum and seemed to decrease after 6 months of treatment, although this did not reach statistical significance after correction for multiple testing. Two types of untargeted metabolomics analyses in sputum showed a change in metabolic composition between 3 and 9 months that almost returned to baseline levels after 12 months of treatment. The volatile metabolic composition of breath was significantly different after 3 months and remained different from baseline until 12 months follow-up. Conclusions: After starting CF transmembrane conductance regulator (CFTR) modulating treatment in CF patients with a homozygous Phe508del mutation, a temporary and moderate change in the lung microbiome is observed, which is mainly characterised by a reduction in the relative abundance of Pseudomonas aeruginosa